Search research articles
Contact Us
Filters
Showing results (21-30 of 72) with videos related to
Page
of 8
Sort By:
Rheumatology (Oxford, England)
|
May 24, 2008
Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA
J C Parker, R W Burlingame, T T Webb, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 29, 2002
Implications for matrix metalloproteinases as modulators of pediatric lung disease
Margaret K Winkler, Jane K Foldes, Robert C Bunn, et al.
Rheumatology (Oxford, England)
|
October 16, 2001
Anti-fibrillarin antibodies in systemic sclerosis
V J Tormey, C C Bunn, C P Denton, et al.
Journal of Cellular and Molecular Medicine
|
March 12, 2026
The SGLT2 Inhibitor Canagliflozin Promotes β-Cell Regeneration and Restores and Stabilises β-Cell Identity in a Polygenic Model of Severe Early-Onset Type 2 Diabetes
Iuliana Popescu, Robert C Bunn, Phil Ray, et al.
The Journal of Biological Chemistry
|
May 10, 1996
C-terminal mutations that alter the turnover number for 3-O-methylglucose transport by GLUT1 and GLUT4
R Dauterive, S Laroux, R C Bunn, et al.
British Journal of Rheumatology
|
March 6, 1998
Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis
C C Bunn, C P Denton, X Shi-Wen, et al.
British Journal of Rheumatology
|
May 6, 1998
HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients
G C Fanning, K I Welsh, C Bunn, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 1, 1997
Anti-PL 4 in patients with systemic lupus erythematosus with severe renal and haematological disease
C Marguerie, C C Bunn, C M Black, et al.
Annals of the Rheumatic Diseases
|
October 1, 1977
Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups
D M Grennan, C Bunn, G R Hughes, et al.
Journal of Clinical Pathology
|
August 18, 1999
Atypical C-ANCA following high dose intravenous immunoglobulin
S Jolles, S Deacock, W Turnbull, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 72) with videos related to
Sort By:
Page
of 8
Rheumatology (Oxford, England)
|
May 24, 2008
Anti-RNA polymerase III antibodies in patients with systemic sclerosis detected by indirect immunofluorescence and ELISA
J C Parker, R W Burlingame, T T Webb, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 29, 2002
Implications for matrix metalloproteinases as modulators of pediatric lung disease
Margaret K Winkler, Jane K Foldes, Robert C Bunn, et al.
Rheumatology (Oxford, England)
|
October 16, 2001
Anti-fibrillarin antibodies in systemic sclerosis
V J Tormey, C C Bunn, C P Denton, et al.
Journal of Cellular and Molecular Medicine
|
March 12, 2026
The SGLT2 Inhibitor Canagliflozin Promotes β-Cell Regeneration and Restores and Stabilises β-Cell Identity in a Polygenic Model of Severe Early-Onset Type 2 Diabetes
Iuliana Popescu, Robert C Bunn, Phil Ray, et al.
The Journal of Biological Chemistry
|
May 10, 1996
C-terminal mutations that alter the turnover number for 3-O-methylglucose transport by GLUT1 and GLUT4
R Dauterive, S Laroux, R C Bunn, et al.
British Journal of Rheumatology
|
March 6, 1998
Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis
C C Bunn, C P Denton, X Shi-Wen, et al.
British Journal of Rheumatology
|
May 6, 1998
HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients
G C Fanning, K I Welsh, C Bunn, et al.
QJM : Monthly Journal of the Association of Physicians
|
May 1, 1997
Anti-PL 4 in patients with systemic lupus erythematosus with severe renal and haematological disease
C Marguerie, C C Bunn, C M Black, et al.
Annals of the Rheumatic Diseases
|
October 1, 1977
Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups
D M Grennan, C Bunn, G R Hughes, et al.
Journal of Clinical Pathology
|
August 18, 1999
Atypical C-ANCA following high dose intravenous immunoglobulin
S Jolles, S Deacock, W Turnbull, et al.
Page
of 8